Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
Matthew Kaplan Maintained (TGTX) at Strong Buy with Increased Target to $38 on, May 2nd, 2023
Matthew Kaplan of Ladenburg Thalmann, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $26 to $38 on, May 2nd, 2023.
Matthew has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $34 on, Monday, May 1st, 2023
- Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
- Joshua Schimmer of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Tuesday, January 24th, 2023
